The rising trend in cancer mortality has been curbed
癌症死亡率上升趋势得到遏制
国家卫生健康委11月15日召开新闻发布会，国家卫生健康委医疗应急司司长郭燕红在会上表示，癌症发病率、死亡率上升的趋势得到初步遏制。
我国人群高发的食管癌、胃癌、肝癌标化的发病率逐年下降，经过努力，我国总体癌症5年生存率从2015年的40.5%上升到了2022年的43.7%。
On November 15, the National Health Commission held a press conference, where Guo Yanhong, Director of the Medical Emergency Department of the National Health Commission, stated that the rising trends in cancer incidence and mortality have been preliminarily contained.
The standardized incidence rates of esophageal cancer, gastric cancer, and liver cancer, which are high-incidence cancers in China, have been decreasing year by year. Through efforts, the overall 5-year survival rate for cancer in China has increased from 40.5% in 2015 to 43.7% in 2022.
